Asia Pacific GMP Cytokines Market

Market Introduction

Cytokines play a significant role in regulating innate and adaptive immunity, which enable cells of the immune system to communicate over short distances. The cytokine therapy to activate cancer patients' immune systems has been an essential parameter in the treatment. Moreover, some cytokines indirectly inhibit tumor growth by stimulating the cytotoxic activity of immune cells against tumor cells.

Market Overview and Dynamics

The Asia Pacific GMP cytokines market is expected to reach US$ 33.37 million by 2027 from US$ 17.27 million in 2019; it is estimated to grow at a CAGR of 8.6% from 2020 to 2027. The growth of the Asia Pacific GMP cytokines market is attributed to key driving factors, such as increase in acceptance of cytokines for cancer and autoimmune therapies and potential contribution in stem cell therapy. However, high cost associated with GMP cytokines therapy is expected to obstruct the growth of the market to a certain extent during the forecast period. 

Key Market Segments

Based on type, the Asia Pacific GMP cytokines market is segmented into TNF, interleukins, growth factors, and others. The growth factors segment held the largest share of the market in 2019, whereas, the TNF segment is expected to register the highest CAGR in the market during the forecast period.

In terms of application, the Asia Pacific GMP cytokines market is categorized into cell and gene therapy, tissue-engineered products, and others. The cell and gene therapy segment held the largest share of the market in 2019; however, the tissue-engineered products segment is anticipated to register the highest CAGR in the market during the forecast period.

Major Sources and Companies Listed

A Few of the primary and secondary sources associated with this report on the Asia Pacific gmp cytokines market are the Japanese Society of Interferon and Cytokine Research (JSICR), International Stem Cell Corporation (ISCO) and Centers for Disease Control and Prevention (CDC).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of the Asia Pacificgmp cytokines market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the Asia Pacificgmp cytokines market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within theAsia Pacificgmp cytokines market.

ASIA PACIFICGMP CYTOKINES SEGMENTATION

 ByType

• TNF
• Interleukin
• Growth Factor
• Others

By Application

• Cell and Gene Therapy
• Tissue-Engineered Products
• Others

By Country

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Company Profiles

• Miltenyi Biotec
• Sino Biological Inc.
• ABCAM
• PeproTech, Inc.
• Akron Biotech
• BIO-TECHNE CORPORATION
• CREATIVE BIOARRAY
• Proteintech Group, Inc.
• REPROCELL, Inc.

Asia Pacific GMP Cytokines Market Strategic Insights

Asia Pacific GMP Cytokines Market Segmentation Analysis

Asia Pacific GMP Cytokines Market Report Highlights

Asia Pacific GMP Cytokines Report Scope

Asia Pacific GMP Cytokines Market Country and Regional Insights